C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2004
12/30/2004	US20040265321 A dimeric fusion protein having two identical polypeptide chains, each chain wtih an extracellular region of an activating Fc gamma R containing an Fc binding site, joined to a molecule that binds an Fc gamma Rn; dimeric fusion protein specifically binds an immune complex
12/30/2004	US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid
12/30/2004	US20040265317 Methods and compositions useful for inhibition of angiogenesis
12/30/2004	US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative
12/30/2004	US20040265307 Anti-IGF-I receptor antibody
12/30/2004	US20040265306 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
12/30/2004	US20040265303 Anti-CCR2 antibodies and methods of use therefor
12/30/2004	US20040265280 Phoma sp. SANK 13899 (FERM BP-6851) strain; produce fungicide through fermentation process; obtained from a soil sample collected in Chichi-island, Ogasawara-mura, Tokyo
12/29/2004	WO2004113548A2 Distillers solubles as a constituent for nisin and lactic acid production from dairy cheese by products
12/29/2004	WO2004113530A1 Polynucleotide for synthesis of labeled protein
12/29/2004	WO2004113522A1 New biological entities and the pharmaceutical or diagnostic use thereof
12/29/2004	WO2004113521A1 New biological entities and the use thereof
12/29/2004	WO2004113500A2 B7s1: an immune modulator
12/29/2004	WO2004113497A2 Gene delivery to tumors
12/29/2004	WO2004113493A2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
12/29/2004	WO2004113376A1 Modified oleosins
12/29/2004	WO2004112703A2 Interleukin-21 analogs
12/29/2004	WO2004096999A3 In vitro translation system
12/29/2004	WO2004096124A3 Compositions and methods for the diagnosis and treatment of tumor
12/29/2004	WO2004082640A3 Human serum albumin conjugates with therapeutic compounds
12/29/2004	WO2004074458A3 N-acetylglucosaminyltransferase iii expression in lower eukaryotes
12/29/2004	WO2004023509A9 Metalized polyester film with heat-seal layer on opposite side for flyback transformer application
12/29/2004	WO2003099847A3 Method for enzymatic production of glp-1 (7-36) amide peptides
12/29/2004	WO2003087128A3 Secretory signal sequences and uses thereof
12/29/2004	WO2003057178A3 Viral capsid assembly intermediates
12/29/2004	WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491550A1 31 human secreted proteins
12/29/2004	EP1490768A1 Adaptive behavioral intrusion detection systems and methods
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490677A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
12/29/2004	EP1490514A2 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification
12/29/2004	EP1490494A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
12/29/2004	EP1490483A2 In vivo incorporation of unnatural amino acids
12/29/2004	EP1490482A1 Host cells having improved cell survival properties and methods to generate such cells
12/29/2004	EP1490481A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490394A1 Method and apparatus for the identification and qualification of biomolecules
12/29/2004	EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004	EP1490085A2 Fc receptor homolog, reagents, and uses thereof
12/29/2004	EP1284998B1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
12/29/2004	EP1278883B1 E. coli extract for protein synthesis
12/29/2004	EP1147137A4 Methods for generating phosphorylation site-specific immunological reagents
12/29/2004	EP1117808B1 Transformation system in the field of filamentous fungal hosts: in chrysosporium
12/29/2004	EP0830130B9 Tnf-alpha converting enzyme
12/29/2004	EP0785946B1 Materials for the production of nanometer structures and use thereof
12/29/2004	EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS
12/29/2004	EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004	CN1558952A Pegylated and diglycosylated erythropoietin
12/29/2004	CN1558947A Peptide synthase gene, peptide synthase and process for producing dipdptide
12/29/2004	CN1558916A Compositions and methods for generating chimeric heteromultimers
12/29/2004	CN1558912A Method for making acylated polypeptides
12/29/2004	CN1557961A Biologic preparation method of cyclic dipeptide analogue compound and uses thereof
12/29/2004	CN1557960A Method for separating antibiotic peptide and separated antibiotic peptide
12/29/2004	CN1557959A Enzyme hydrolysis protein liquor and deposition removal production process
12/29/2004	CN1557948A Method for parameter control of the process for culturing serum-suspension free animal cell
12/29/2004	CN1557835A Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same
12/29/2004	CN1557482A Immune function regulating and tumor resisting natural nutrient
12/29/2004	CN1557481A Natural nutrient for preventing and treating iron-deficiency anemia
12/29/2004	CN1557476A Multiple biological activity polypeptide nutrient
12/29/2004	CN1557475A Beautifying and fat reducing nutrients composition
12/29/2004	CN1557474A Blood pressure reducing natural polypeptide nutrient
12/29/2004	CN1557471A Nutrient for preventing and treating type II diabetes and X-syndrome
12/29/2004	CN1557470A Natural nutrient for preventing and treating multiple oral disease
12/29/2004	CN1557469A Natural calcium replenishing nutrient
12/29/2004	CN1557281A Skin apolexis preventing delaying polypeptide and compositions
12/29/2004	CN1557278A Skin, hair growth nutrient promotor
12/29/2004	CN1182155C Recombinant human hepatocyte auxin, its preparing process and its clinical application
12/29/2004	CA2529659A1 Engineered proteolytic enzyme with altered specificity determining regions
12/29/2004	CA2529589A1 New biological entities and the pharmaceutical or diagnostic use thereof
12/29/2004	CA2529520A1 Interleukin-21 analogs
12/29/2004	CA2529142A1 Rna interferases and methods of use thereof
12/29/2004	CA2528845A1 Modified oleosins
12/29/2004	CA2525379A1 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
12/28/2004	US6835821 Useful mutations of bacterial alkaline protease
12/28/2004	US6835817 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
12/28/2004	US6835816 Mammalian tumor susceptibility genes and their uses
12/28/2004	US6835813 Testis-specific differentiation-regulatory factor
12/28/2004	US6835809 Thrombopoietic compounds
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835370 Diagnosis and treatment of malignant neoplasms
12/28/2004	CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
12/23/2004	WO2004111246A1 Protein production system
12/23/2004	WO2004111240A2 Sequence for the bacillomycin d synthesis in bacillus amyloliquefaciens fzb42
12/23/2004	WO2004111228A1 Methods for producing secreted polypeptides
12/23/2004	WO2004111203A1 Extract from cultured mammalian cell, process for preparation thereof and method of cell-free protein synthesis using the extract
12/23/2004	WO2004111194A2 Method to increase protein production in culture
12/23/2004	WO2004111076A1 Triamide derivative and process for producing the same
12/23/2004	WO2004111074A2 In vivo production of a clostridial neurotoxin light chain peptide
12/23/2004	WO2004110466A2 Pediocin-producing pediococci
12/23/2004	WO2004110139A1 Process for producing human-origin immunocompetent cell
12/23/2004	WO2004090151A3 Method for extracting collagen comprising microbial fermentation
12/23/2004	WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/23/2004	WO2003076569A3 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same
12/23/2004	WO2003050236A3 Human genes and gene expression products isolated from human prostate
12/23/2004	US20040260069 Modified anti-tnf aplha antibody
12/23/2004	US20040260067 Chimpanzee monoclonal antibodies and antigen binding fragments including complementary determining regions; drug screening; host cells; kits
12/23/2004	US20040260065 Interleukins; immunoglobulins; for stimulating proliferation and/or development of hematopoietic cells in vitro and in vivo

1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 1125